This event is bringing together the industry-leading experts in protein degrader drug development for neurodegenerative diseases. The highly interdisciplinary nature of this field of focus and involves specialists ranging from neuroscientists to medicinal chemists to pharmacologists and is therefore ripe for building long lasting partnerships.
Be a part of this fast-growing and exciting area for novel therapeutics as the race is on towards clinic for protein degradation drugs targeting CNS diseases.
What is the Industry Looking For?
Pharmacokinetic imaging and analysis
Animal models
Toxicology and ADME assays
CNS and human disease models
Protein degrader screening platforms
Why Partner?
Raise the awareness of the services and solutions provided by your company as the field becomes heavily focused on translation towards Phase I clinical trials
Generate commercial opportunities within this highly interdisciplinary field of neuroscientists, medicinal chemists and protein degradation experts and distinguish yourselves as the best industry collaborators
Brush shoulders with experts in the space to uncover the approaches that have gained momentum with preclinical success to aid strategic planning for future directions
Who Will You Meet?
80+ neuroscientists, structural and chemical biologists, medicinal chemists, pharmacologists and protein degrader experts from the leading biotechnology and pharmaceutical companies in the industry.
We would love to work with you and tailor your involvement to communicate your solutions and expertise to the decision-makers in the field, generate leads, and develop next-generation partnerships
Partnership's Representative:
Glenn Butler